Nurix Therapeutics (NRIX) Return on Equity (ROE) (2019 - 2026)
Nurix Therapeutics (NRIX) Return on Equity (ROE) from Feb 28, 2019 to May 31, 2026. The TTM Nurix Therapeutics (NRIX) Return on Equity (ROE) is -22.24%. You can export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual ROE
Quarterly ROE
Annual Return on Equity (ROE) change of Nurix Therapeutics (NRIX)
| Year | Return on Equity (ROE) | Change |
|---|---|---|
| 2025 | -49.09% | +33.64% |
| 2024 | -36.73% | -48.84% |
| 2023 | -71.80% | +20.90% |
| 2022 | -59.39% | +73.46% |
| 2021 | -34.24% | +129.83% |
| 2020 | -14.90% | -139.62% |
| 2019 | 37.60% | N/A |